First Eagle Investment Management
BIIB icon

First Eagle Investment Management’s Biogen BIIB Stock Holding History

First Eagle Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-57,300
Closed -$15.3M – 103
2020
Q2 		$15.3M Buy
+57,300
New +$17.2M 0.05% 90
2017
Q1 		– Sell
-257,025
Closed -$72.7M – 323
2016
Q4 		$72.9M Sell
257,025
-200,235
-44% -$59.4M 0.19% 96
2016
Q3 		$143M Buy
457,260
+124,500
+37% +$36.9M 0.36% 76
2016
Q2 		$80.5M Buy
332,760
+108,175
+48% +$28.5M 0.21% 104
2016
Q1 		$58.5M Buy
224,585
+30,700
+16% +$8.11M 0.15% 120
2015
Q4 		$59.4M Buy
+193,885
New +$55.7M 0.15% 120

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Eagle Investment Management's BIIB Position: Q3 2020 in Review

First Eagle Investment Management sold out of Biogen (BIIB) in Q3 2020, closing a stake of 57,300 shares — an estimated $15.3M sold.

First Eagle Investment Management first reported a position in BIIB in Q4 2015 and held it in 6 quarters. The position peaked at $143M in Q3 2016. 1,051 funds tracked by Wall St. Rank hold BIIB as of Q3 2020.

  • First Eagle Investment Management reported no remaining Biogen position as of Q3 2020 after selling out during the quarter.
  • First Eagle Investment Management sold 57,300 Biogen shares in Q3 2020, an estimated $15.3M.
  • First Eagle Investment Management first reported a position in Biogen in Q4 2015 and held it in 6 quarters.
  • First Eagle Investment Management's Biogen position peaked at $143M in Q3 2016.
  • 1,051 funds tracked by Wall St. Rank held Biogen as of Q3 2020.

Based on First Eagle Investment Management's 13F filing for Q3 2020, filed 10 Nov 2020.